<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2017-8-8-12</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-1815</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФЕКЦИИ В ОТОРИНОЛАРИНГОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INFECTIONS IN OTORHINOLARYNGOLOGY</subject></subj-group></article-categories><title-group><article-title>ВОЗМОЖНОСТИ ИММУНОСТИМУЛИРУЮЩЕЙ ТЕРАПИИ ПРИ РЕСПИРАТОРНЫХ ИНФЕКЦИЯХ ВЕРХНИХ ДЫХАТЕЛЬНЫХ  ПУТЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>POSSIBILITIES OF IMMUNOSTIMULATING THERAPY IN RESPIRATORY INFECTIONS OF UPPER RESPIRATORY TRACTS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Свистушкин</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Svistushkin</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор</p></bio><bio xml:lang="en"><p>MD, Prof.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Старостина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Starostina</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор</p></bio><bio xml:lang="en"><p>MD, Prof.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аветисян</surname><given-names>Э. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Avetisyan</surname><given-names>E. E.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селезнева</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Selezneva</surname><given-names>L. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical Univeristy of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>12</day><month>05</month><year>2017</year></pub-date><volume>0</volume><issue>8</issue><fpage>8</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Свистушкин В.М., Старостина С.В., Аветисян Э.Е., Селезнева Л.В., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Свистушкин В.М., Старостина С.В., Аветисян Э.Е., Селезнева Л.В.</copyright-holder><copyright-holder xml:lang="en">Svistushkin V.M., Starostina S.V., Avetisyan E.E., Selezneva L.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/1815">https://www.med-sovet.pro/jour/article/view/1815</self-uri><abstract><p>В статье кратко изложены механизмы воздействия бактериальных лизатов на иммунную систему. На примере препарата Исмиген® (поливалентный механический  бактериальный лизат (ПМБЛ)) приведена доказательная база возможных механизмов коррекции иммунной системы при респираторных заболеваниях верхних дыхательных путей (ВДП), а также анализ данных клинической эффективности препарата.</p></abstract><trans-abstract xml:lang="en"><p>The article summarizes the action mechanisms of bacterial lysates of the immune system. On the example of Ismigen shown evidence based possible correction mechanisms of the immune system in inflammatory diseases of the upper respiratory tract by bacterial lysates.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>заболевания ВДП</kwd><kwd>иммуностимулирующая терапия</kwd><kwd>бактериальные лизаты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>URT diseases</kwd><kwd>immunostimulatory therapy</kwd><kwd>bacterial lysates</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cazzola M, Anapurapu S, Page CP. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a metaanalysis. Pulm Pharmacol Ther, 2012, 25: 62-68.</mixed-citation><mixed-citation xml:lang="en">Cazzola M, Anapurapu S, Page CP. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a metaanalysis. Pulm Pharmacol Ther, 2012, 25: 62-68.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Артюшкин С.А., Еремина Н.В. Дифференциальная диагностика и рациональная терапия вирусных поражений верхних дыхательных путей. РМЖ, 2016, 4: 245-250.</mixed-citation><mixed-citation xml:lang="en">Артюшкин С.А., Еремина Н.В. Дифференциальная диагностика и рациональная терапия вирусных поражений верхних дыхательных путей. РМЖ, 2016, 4: 245-250.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Маркова Т.П., Ярилина Л.Г., Чувирова А.Г. Бактериальные лизаты. Новые препараты. РМЖ, 2014, 24: 1764.</mixed-citation><mixed-citation xml:lang="en">Маркова Т.П., Ярилина Л.Г., Чувирова А.Г. Бактериальные лизаты. Новые препараты. РМЖ, 2014, 24: 1764.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Морозова С.В. Возможности применения препарата Иммунал при воспалительных заболеваниях верхних дыхательных путей. РМЖ, 2006, 22: 1608.</mixed-citation><mixed-citation xml:lang="en">Морозова С.В. Возможности применения препарата Иммунал при воспалительных заболеваниях верхних дыхательных путей. РМЖ, 2006, 22: 1608.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lanzilli G, Falchetti R, Tricarico M et al. In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int J Immunopathol Pharmacol, 2005, 18: 245-54.</mixed-citation><mixed-citation xml:lang="en">Lanzilli G, Falchetti R, Tricarico M et al. In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int J Immunopathol Pharmacol, 2005, 18: 245-54.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lanzilli G, Falchetti R, Cottarelli A et al: In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmacol, 2006, 19: 551-59.</mixed-citation><mixed-citation xml:lang="en">Lanzilli G, Falchetti R, Cottarelli A et al: In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmacol, 2006, 19: 551-59.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rosaschino F, Cattaneo L: Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL). Acta Biome, 2004, 75: 171-78.</mixed-citation><mixed-citation xml:lang="en">Rosaschino F, Cattaneo L: Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL). Acta Biome, 2004, 75: 171-78.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Faure GC, Béné MC, Simon C, Quantain A: Increase in specific antibodyforming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine. Int J Immunopharmaco, 1990, 12: 315-20.</mixed-citation><mixed-citation xml:lang="en">Faure GC, Béné MC, Simon C, Quantain A: Increase in specific antibodyforming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine. Int J Immunopharmaco, 1990, 12: 315-20.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Han L, Zheng CP, Sun YQ et al: A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. Am J Rhinol Allergy, 2014, 28: 110-16.</mixed-citation><mixed-citation xml:lang="en">Han L, Zheng CP, Sun YQ et al: A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. Am J Rhinol Allergy, 2014, 28: 110-16.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bitar MA, Saade R: The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children. Int J PediatrOtorhinolaryngol, 2013, 77: 670-73.</mixed-citation><mixed-citation xml:lang="en">Bitar MA, Saade R: The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children. Int J PediatrOtorhinolaryngol, 2013, 77: 670-73.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ricci R, Palmero C, Bazurro G et al: The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes. Pulm Pharmacol Ther, 2014, 27: 109-13.</mixed-citation><mixed-citation xml:lang="en">Ricci R, Palmero C, Bazurro G et al: The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes. Pulm Pharmacol Ther, 2014, 27: 109-13.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Guaní-Guerra E, Negrete-García MC, MontesVizuet R et al: Human b-defensin-2 induction in nasal mucosa after administration of bacterial lysates. Arch Med Res, 2011, 42: 189-94.</mixed-citation><mixed-citation xml:lang="en">Guaní-Guerra E, Negrete-García MC, MontesVizuet R et al: Human b-defensin-2 induction in nasal mucosa after administration of bacterial lysates. Arch Med Res, 2011, 42: 189-94.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zagólski O, Stręk P, Kasprowicz A, Białecka A. Effectiveness of Polyvalent Bacterial Lysate and AutovaccinesAgainst Upper Respiratory Tract Bacterial Colonization by Potential Pathogens: A Randomized Study. Med SciMonit, 2015, 21: 2997-3002.</mixed-citation><mixed-citation xml:lang="en">Zagólski O, Stręk P, Kasprowicz A, Białecka A. Effectiveness of Polyvalent Bacterial Lysate and AutovaccinesAgainst Upper Respiratory Tract Bacterial Colonization by Potential Pathogens: A Randomized Study. Med SciMonit, 2015, 21: 2997-3002.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">La Mantia I, Nicolozi F et al. Immunoprophylaxis of recurring bacterial infections of respiratory tracts in pediatric age: clinical experience through a new immune stimulating vaccine. GIMMOC, 2007.</mixed-citation><mixed-citation xml:lang="en">La Mantia I, Nicolozi F et al. Immunoprophylaxis of recurring bacterial infections of respiratory tracts in pediatric age: clinical experience through a new immune stimulating vaccine. GIMMOC, 2007.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Fokkens WJ, Lund VJ, Mullol J. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology, 2012, 50(1): 1-12.</mixed-citation><mixed-citation xml:lang="en">Fokkens WJ, Lund VJ, Mullol J. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology, 2012, 50(1): 1-12.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Aksic OT et al. Evaluation of the clinical efficacy of a new polyvalent bacterial lysate obtained by mechanical lysis (PMBLTM) in a population of 180 school-aged children with recurrent respiratory infections. European journal of aerobiology environmental medicine and air-borne infections, 2005.</mixed-citation><mixed-citation xml:lang="en">Aksic OT et al. Evaluation of the clinical efficacy of a new polyvalent bacterial lysate obtained by mechanical lysis (PMBLTM) in a population of 180 school-aged children with recurrent respiratory infections. European journal of aerobiology environmental medicine and air-borne infections, 2005.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Карпова Е.П., Тулупов Д.А., Вагина Е.Е. Возможности профилактики и лечения лимфаденотонзиллярной патологии. РМЖ, 2014, 25: 1842.</mixed-citation><mixed-citation xml:lang="en">Карпова Е.П., Тулупов Д.А., Вагина Е.Е. Возможности профилактики и лечения лимфаденотонзиллярной патологии. РМЖ, 2014, 25: 1842.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнов А.Г., Драгунов Д.О., Соколова А.В. Место бактериальных лизатов в терапии рецидивирующих бактериальных инфекций. РМЖ, 2014, 31: 2176.</mixed-citation><mixed-citation xml:lang="en">Арутюнов А.Г., Драгунов Д.О., Соколова А.В. Место бактериальных лизатов в терапии рецидивирующих бактериальных инфекций. РМЖ, 2014, 31: 2176.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Вирясов А.В., Трифонова Н.Ю., Шеховцов С.Ю. Применение SWOT-анализа при оценке организации медицинской помощи лицам пожилого возраста. М., 2013.</mixed-citation><mixed-citation xml:lang="en">Вирясов А.В., Трифонова Н.Ю., Шеховцов С.Ю. Применение SWOT-анализа при оценке организации медицинской помощи лицам пожилого возраста. М., 2013.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
